Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin

Neuroscience

Volumn 97, Issue 1, 2000, Pages 47-58

  Bouilleret, V ^a   Schwaller, B ^b   Schurmans, S ^c   Celio, M R ^b   Fritschy, J M ^d  

^a INSERM   (France)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

^c IBMM   (Belgium)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

GABA(A) receptor; Interneurons; Kainic acid; Knockout mice; Mesial temporal lobe epilepsy; Neuropeptides

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; EXCITOTOXIN; KAINIC ACID; MARKER; NEUROPEPTIDE Y; PARVALBUMIN; RECEPTOR SUBUNIT; SOMATOSTATIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FOCAL EPILEPSY; GABAERGIC SYSTEM; GENE DELETION; GENE EXPRESSION; GRANULE CELL; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTERNEURON; KNOCKOUT MOUSE; MORPHOGENESIS; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPORAL LOBE EPILEPSY;

ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; EXCITATORY AMINO ACID AGONISTS; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; KAINIC ACID; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; NEURODEGENERATIVE DISEASES; NEUROPEPTIDE Y; ORGANIC ANION TRANSPORTERS; PARVALBUMINS; RECEPTORS, GABA-A; SEIZURES; SOMATOSTATIN;

EID: 0034044955     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00017-8     Document Type: Article

References (64)

1. Airaksinen M.S., Eilers J., Garaschuk O., Thoenen H., Konnerth A., Meyer M. Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene. Proc. natn. Acad. Sci. U.S.A. 94:1997;1488-1493.
2. Baimbridge K.G., Miller J.J. Immunohistochemical localization of calcium-binding protein in the cerebellum, hippocampal formation and olfactory bulb of the rat. Brain Res. 245:1982;223-229.
3. Baraban S.C., Hollopeter G., Erickson J.C., Schwartzkroin P.A., Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17:1997;8927-8936.
4. Blasco-Ibanez J.M., Freund T.F. Distribution, ultrastructure, and connectivity of calretinin-immunoreactive mossy cells of the mouse dentate gyrus. Hippocampus. 7:1997;307-320.
5. Bleakman D., Harrison N.L., Colmers W.F., Miller R.J. Investigations into neuropeptide Y-mediated inhibition in cultured hippocampal neurones of the rat. Br. J. Pharmac. 107:1992;334-340.
6. Borden L.A. GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem. Int. 29:1996;335-356.
7. A-receptor expression in a mouse model of temporal lobe epilepsy (TLE). Soc. Neurosci. Abstracts. 25:1999a;846.
8. Bouilleret V., Ridoux V., Depaulis A., Marescaux C., Nehlig A., Le Gal La Salle G. Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: EEG, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience. 89:1999;717-729.
9. Canossa M., Griesbeck O., Berninger B., Campana G., Kolbeck R., Thoenen H. Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity. Proc. natn. Acad. Sci. U.S.A. 94:1997;13,279-13,286.
10. Carnahan J., Nawa H. Regulation of neuropeptide expression in the brain by neurotrophins. Potential role in vivo. Molec. Neurobiol. 10:1995;135-149.
11. Celio M.R. GABA neurons contain the calcium binding protein parvalbumin. Science. 232:1986;995-997.
12. Celio M.R. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience. 35:1990;375-475.
13. Chard P.S., Bleakman D., Christakos S., Fullmer C.S., Miller R.J. Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurones. J. Physiol., Lond. 472:1993;341-357.
14. Chard P.S., Jordna J., Marcuccilli C.J., Miller R.J., Leiden J.M., Roos R.P., Ghadge G.D. Regulation of excitatory transmission at hippocampal synapses by calbindin D28k. Proc. natn. Acad. Sci. U.S.A. 92:1995;5144-5148.
15. Croll S.D., Wiegand S.J., Anderson K.D., Lindsay R.M., Nawa H. Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF. Eur. J. Neurosci. 6:1994;1343-1353.
16. de Lanerolle N.C., Kim J.H., Robbins R.J., Spencer D.D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495:1989;387-395.
17. During M.J., Ryder K.M., Spencer D.D. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature. 376:1995;174-177.
18. El Bahh B., Lurton D., Sundstrom L.E., Rougier A. Induction of tolerance and mossy fibre neuropeptide Y expression in the contralateral hippocampus following a unilateral intrahippocampal kainic acid injection in the rat. Neurosci. Lett. 227:1997;135-139.
19. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures in mice lacking neuropeptide Y. Nature. 381:1996;377-378.
20. Freund T.F., Buzsaki G. Interneurons of the hippocampus. Hippocampus. 6:1996;345-470.
21. Freund T.F., Buzsaki G., Leon A., Baimbridge K.G., Somogyi P. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Expl Brain Res. 83:1990;55-66.
22. Freund T.F., Magloczky Z. Early degeneration of calretinin-containing neurons in the rat hippocampus after ischemia. Neuroscience. 56:1993;581-596.
23. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. comp. Neurol. 359:1995;154-194.
24. Fujise N., Liu Y., Hori N., Kosaka T. Distribution of calretinin immunoreactivity in the mouse dentate gyrus: II. Mossy cells, with special reference to their dorsoventral difference in calretinin immunoreactivity. Neuroscience. 82:1998;181-200.
25. Gall C., Lauterborn J., Bundman M., Murray K., and Isackson P. (1991) Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain. Epilepsy Res., Suppl. 4, 225-245.
26. A-receptors containing the α1-subunit to neurochemically distinct subpopulations of hippocampal interneurons. Eur. J. Neurosci. 6:1994;837-853.
27. Gruber B., Greber S., Rupp E., Sperk G. Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection. Hippocampus. 4:1994;474-482.
28. Gulyas A.I., Miettinen R., Jacobowitz D.M., Freund T.F. Calretinin is present in non-pyramidal cells of the rat hippocampus. I. A new type of neuron specifically associated with the mossy fiber system. Neuroscience. 48:1992;1-27.
29. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
30. Iacopino A.M., Christakos S. Specific reduction of calcium-binding proteins (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc. natn. Acad. Sci. U.S.A. 87:1990;4078-4082.
31. Jones K.R., Farinas I., Backus C., Reichardt L.F. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell. 76:1994;989-999.
32. Kohr G., Lambert C.E., Mody I. Calbindin-D28K (CaBP) levels and calcium currents in acutely dissociated epileptic neurons. Expl Brain Res. 85:1991;543-551.
33. 2+-binding protein parvalbumin in the rat hippocampus and dentate gyrus. Brain Res. 419:1987;119-130.
34. 2+-dependent phosphatase. Nature. 369:1994;235-239.
35. Liu Y., Fujise N., Kosaka T. Distribution of calretinin immunoreactivity in the mouse dentate gyrus. 1 General description. Expl Brain Res. 108:1996;389-403.
36. Lowenstein D.H., Miles M.F., Hatam F., McCabe T. Up regulation of calbindin-D28k in the rat hippocampus following focal stimulation of the perforant path. Neuron. 6:1991;627-633.
37. Lurton D., Cavalheiro E.A. Neuropeptide-Y immunoreactivity in the pilocarpine model of temporal lobe epilepsy. Expl Brain Res. 116:1997;186-190.
38. Lurton D., Coussemacq M., Barrow P., Sundstrom L.E., Rougier A. Widespread ectopic neuropeptide-Y immunoreactivity in contralateral mossy fibres after a unilateral intrahippocampal kainic acid injection in the rat. Neurosci. Lett. 213:1996;181-184.
39. Magloczky Z., Freund T.F. Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield. Neuroscience. 56:1993;317-335.
40. Makiura Y., Suzuki F., Chevalier E., Onteniente B. Excitatory granule cells of the dentate gyrus exhibit a double inhibitory neurochemical content after intrahippocampal administration of kainate in adult mice. Expl Neurol. 159:1999;73-83.
41. Marksteiner J., Ortler M., Bellmann R., Sperk G. Neuropeptide Y biosynthesis is markedly induced in mossy fibers during temporal lobe epilepsy of the rat. Neurosci. Lett. 112:1990;143-148.
42. Marsh D.J., Baraban S.C., Hollopeter G., Palmiter R.D. Role of the Y5 neuropeptide receptor in limbic seizures. Proc. natn. Acad. Sci. U.S.A. 96:1999;13518-13523.
43. Mathern G.W., Mendoza D., Lozada A., Pretorius J.K., Kehnes Y., Danbolt N.C., Nelson N., Leite J.P., Chimelli L., Born D.E., Sakamoto A.C., Assirati J.A., Fried I., Peacock W.J., Ojemann G.A., Adelson P.D. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology. 52:1999;453-472.
44. Miettinen R., Gulyas A.I., Baimbridge K.G., Jacobowitz D.M., Freund T.F. Calretinin is present in non-pyramidal cells of the rat hippocampus. II. Co-existence with other calcium binding proteins and GABA. Neuroscience. 48:1992;29-43.
45. Mockel V., Fischer G. Vulnerability to excitotoxic stimuli of cultured rat hippocampal neurons containing the calcium-binding proteins calretinin and calbindin D28k. Brain Res. 648:1994;109-120.
46. Nawa H., Pelleymounter M.A., Carnahan J. Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J. Neurosci. 14:1994;3751-3765.
47. Resibois A., Rogers J.H. Calretinin in rat brain: an immunohistochemical study. Neuroscience. 46:1992;101-134.
48. Ribak C.E., Tong W.M.Y., Brecha N.C. GABA plasma membrane transporters, GAT-1 and GAT-3, display different distributions in the rat hippocampus. J. comp. Neurol. 367:1996;595-606.
49. Robbins R.J., Brines M.L., Kim J.H., Adrian T., de Lanerolle N.C., Welsh S., Spencer D.D. A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann. Neurol. 29:1992;325-332.
50. Schurmans S., Schiffmann S.N., Gurden H., Lemaire M., Lipp H.P., Schwam V., Pochet R., Imperato A., Bohme G.A., Parmentier M. Impaired long-term potentiation induction in dentate gyrus of calretinin-deficient mice. Proc. natn. Acad. Sci. U.S.A. 94:1997;10415-10420.
51. Schwaller B., Dick J., Dhoot G., Carroll S., Vrbova G., Nicotera P., Pette D., Wyss A., Bluethmann H., Hunziker W., Celio M.R. Prolonged contraction-relaxation cycle of fast-twitch muscles in parvalbumin knockout mice. Am. J. Physiol. 276:1999;C395-C403.
52. Schwarzer C., Sperk G. Hippocampal granule cells express glutamic acid decarboxylase-67 after limbic seizures in the rat. Neuroscience. 69:1995;705-709.
53. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M., Vezzani A. Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res. Rev. 22:1996;27-50.
54. Schwarzer C., Williamson J.M., Lothman E.W., Vezzani A., Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience. 69:1995;831-845.
55. Sloviter R.S. Calcium-binding protein (Calbindin-D28k) and parvalbumin immunohistochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J. comp. Neurol. 280:1989;183-196.
56. Sloviter R.S., Sollas A.L., Barbaro N.M., Laxer K.D. Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J. comp. Neurol. 308:1991;381-396.
57. Sperk G., Marksteiner J., Gruber B., Bellmann R., Mahata M., Ortler M. Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience. 50:1992;831-846.
58. Suzuki F., Junier M.P., Guilhem D., Sorensen J.C., Onteniente B. Morphogenetic effect of kainate on adult hippocampal neurons associated with a prolonged expression of brain-derived neurotrophic factor. Neuroscience. 64:1995;665-674.
59. Tonder N., Kragh J., Finsen B.R., Bolwig T.G., Zimmer J. Kindling induces transient changes in neuronal expression of somatostatin, neuropeptide Y, and calbindin in adult rat hippocampus and fascia dentata. Epilepsia. 35:1994;1299-1308.
60. Toth K., Freund T.F. Calbindin D 28K-containing nonpyramidal cells in the rat hippocampus: their immunoreactivity for GABA and projection to the medial septum. Neuroscience. 49:1992;793-905.
61. Vecellio M., Schwaller B., Meyer M., Hunziker W. and Celio M. R. (1999) Alteration in Purkinje-cell spines of calbindin D-28k and parvalbumin knock-out animals. Eur. J. Neurosci. (in press).
62. Vezzani A., Civenni G., Rizzi M., Monno A., Messali S., Samanin R. Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res. 660:1994;138-143.
63. Woldbye D.P., Larsen P.J., Mikkelsen J.D., Klemp K., Madsen T.M., Bolwig T.G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nature Med. 3:1997;761-764.
64. Woldbye D.P., Madsen T.M., Larsen P.J., Mikkelsen J.D., Bolwig T.G. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res. 737:1996;162-168.